• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. INDIGO SYSTEM LIGHTNING 12; QEW

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. INDIGO SYSTEM LIGHTNING 12; QEW Back to Search Results
Model Number LITNG12HTORQ115-A
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Death (1802); Perforation (2001)
Date of Event 11/09/2020
Type of Reportable Event Death
Additional Manufacturer Narrative
The product was not returned for evaluation.From the information provided, there is no indication that there was any device malfunction, nonconformance, or misuse that contributed to the reported event.Potential adverse events in the labeling with the indigo aspiration system include, but are not limited to, vascular complications (including vessel spasm, thrombosis, intimal disruption, dissection, or perforation), thromboembolic events, including death.The product lot number was not provided, therefore, the manufacturing records could not be reviewed.
 
Event or Problem Description
The patient was undergoing a thrombectomy procedure to treat a pulmonary embolism using an indigo system aspiration catheter 12 (cat12), lightning aspiration tubing (lightning), a non-penumbra sheath (cook flexor 12fr) and a guidewire (amplatz).During the procedure, the physician placed the sheath in the pulmonary artery, then advanced the cat12 through the sheath.The physician connected the lightning to the cat12 and initiated aspiration.During aspiration, the indicator light on the lightning unit turned yellow and the lightning and cat12 appeared to be occluded.The cat12 was removed to be flushed, but no thrombus was found.The lightning was disconnected and cleared.The physician then placed the cat12 back into the patient, and the cat12 occluded again.The cat12 was removed again, and the sheath was noticed to be occluded.Therefore, the sheath was removed and flushed, then placed back into the patient over the guidewire.An image was taken, and the physician discovered a perforation in the pulmonary artery.The procedure ended at this point.The patient was initially stable.Approximately twenty minutes later, the patient became unstable.The patient expired on the same day, and the patient's death was related to the perforation.It is unknown if the cat12 was in the patient at the time the perforation occurred.It is also unknown which device being used caused the perforation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INDIGO SYSTEM LIGHTNING 12
Common Device Name
QEW
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
MDR Report Key10972658
Report Number3005168196-2020-02219
Device Sequence Number10958184
Product Code QEW
UDI-Device Identifier00815948022577
UDI-Public00815948022577
Combination Product (Y/N)Y
Initial Reporter StateDC
Initial Reporter CountryUS
PMA/510(K) Number
K200771
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 11/09/2020
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberLITNG12HTORQ115-A
Device Catalogue NumberLITNG12HTORQ115
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/09/2020
Initial Report FDA Received Date12/08/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Death;
Patient Age66 YR
Date Report Sent to FDA01/01/2005
-
-